Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells

Biochemical and Biophysical Research Communications

Volumn 432, Issue 4, 2013, Pages 713-719

  Hayakawa, Kazuo ^a,b,d   Ikeya, Makoto ^b   Fukuta, Makoto ^a,b,d   Woltjen, Knut ^b   Tamaki, Sakura ^a   Takahara, Naoko ^a   Kato, Tomohisa ^a   Sato, Shingo ^a,e   Otsuka, Takanobu ^d   Toguchida, Junya ^a,b,c  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ES cells; Expression profile; IPS cells; Regulation; Synovial sarcoma; SYT SSX

Indexed keywords

DOXYCYCLINE; HYBRID PROTEIN; MESSENGER RNA; ONCOPROTEIN; SYT SSX2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; DOWN REGULATION; FUSION GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SYNOVIAL SARCOMA; UPREGULATION;

CELL LINE, TUMOR; COMPUTER SIMULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE TARGETING; GENES, NEOPLASM; HUMANS; ONCOGENE PROTEINS, FUSION; PLURIPOTENT STEM CELLS; SARCOMA, SYNOVIAL; UP-REGULATION;

EID: 84875544559     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.003     Document Type: Article

References (31)

1. Clark J., Rocques P.J., Crew A.J., Gill S., Shipley J., Chan A.M., Gusterson B.A., Cooper C.S. Identification of novel genes, SYT and SSX, involved in the t(X; 18)(p11.2; q11.2) translocation found in human synovial sarcoma. Nat. Genet. 1994, 7:502-508.
2. Brodin B., Haslam K., Yang K., Bartolazzi A., Xie Y., Starborg M., Lundeberg J., Larsson O. Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression. Gene 2001, 268:173-182.
3. Thaete C., Brett D., Monaghan P., Whitehouse S., Rennie G., Rayner E., Cooper C.S., Goodwin G. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. Hum. Mol. Genet. 1999, 8:585-591.
4. Ishida M., Miyamoto M., Naitoh S., Tatsuda D., Hasegawa T., Nemoto T., Yokozeki H., Nishioka K., Matsukage A., Ohki M., Ohta T. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x; 18) synovial sarcoma. Mol. Cell Biol. 2007, 27:1348-1355.
5. Takenaka S., Naka N., Araki N., Hashimoto N., Ueda T., Yoshioka K., Yoshikawa H., Itoh K. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo. Int J. Oncol. 2010, 36:823-831.
6. W. Cai, Y. Sun, W. Wang, C. Han, M. Ouchida, W. Xia, X. Zhao, B. Sun, The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma, Pathol. Oncol. Res. 17 (2011) 357-67.
7. Nagai M., Tanaka S., Tsuda M., Endo S., Kato H., Sonobe H., Minami A., Hiraga H., Nishihara H., Sawa H., Nagashima K. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc. Natl. Acad. Sci. USA 2001, 98:3843-3848.
8. de Bruijn D.R., Allander S.V., van Dijk A.H., Willemse M.P., Thijssen J., van Groningen J.J., Meltzer P.S., van Kessel A.G. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation. Cancer Res. 2006, 66:9474-9482.
9. Cironi L., Provero P., Riggi N., Janiszewska M., Suva D., Suva M.L., Kindler V., Stamenkovic I. Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1. PLoS One 2009, 4:e7904.
10. Garcia C.B., Shaffer C.M., Alfaro M.P., Smith A.L., Sun J., Zhao Z., Young P.P., VanSaun M.N., Eid J.E. Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. Oncogene 2011, 31:2323-2334.
11. Tschoep K., Kohlmann A., Schlemmer M., Haferlach T., Issels R.D. Gene expression profiling in sarcomas. Crit. Rev. Oncol. Hematol. 2007, 63:111-124.
12. Haldar M., Hancock J.D., Coffin C.M., Lessnick S.L., Capecchi M.R. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer cell 2007, 11:375-388.
13. Jones K.B., Su L., Jin H., Lenz C., Randall R.L., Underhill T.M., Nielsen T.O., Sharma S., Capecchi M.R. SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas. Oncogene 2012.
14. Nagayama S., Katagiri T., Tsunoda T., Hosaka T., Nakashima Y., Araki N., Kusuzaki K., Nakayama T., Tsuboyama T., Nakamura T., Imamura M., Nakamura Y., Toguchida J. Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res. 2002, 62:5859-5866.
15. Ang Y.S., Gaspar-Maia A., Lemischka I.R., Bernstein E. Stem cells and reprogramming: breaking the epigenetic barrier?. Trends Pharmacol. Sci. 2011, 32:394-401.
16. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., Cowling R., Wang W., Liu P., Gertsenstein M., Kaji K., Sung H.K., Nagy A. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
17. Suemori H., Yasuchika K., Hasegawa K., Fujioka T., Tsuneyoshi N., Nakatsuji N. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem. Biophys. Res. Commun. 2006, 345:926-932.
18. Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., Hong H., Nakagawa M., Tanabe K., Tezuka K., Shibata T., Kunisada T., Takahashi M., Takahashi J., Saji H., Yamanaka S. A more efficient method to generate integration-free human iPS cells. Nat. Methods 2011, 8:409-412.
19. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
20. Kohno Y., Okamoto T., Ishibe T., Nagayama S., Shima Y., Nishijo K., Shibata K.R., Fukiage K., Otsuka S., Uejima D., Araki N., Naka N., Nakashima Y., Aoyama T., Nakayama T., Nakamura T., Toguchida J. Expression of claudin7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3. J. Biol. Chem. 2006, 281:38941-38950.
21. Nasu A., Ikeya M., Yamamoto T., Watanabe A., Jin Y., Matsumoto Y., Hayakawa K., Amano N., Sato S., Osafune K., Aoyama T., Nakamura T., Kato T., Toguchida J. Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin. PLos One 2013, 8:e53771.
22. Garcia C.B., Shaffer C.M., Eid J.E. Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2. BMC Genomics 2012, 13:189.
23. Su L., Sampaio A.V., Jones K.B., Pacheco M., Goytain A., Lin S., Poulin N., Yi L., Rossi F.M., Kast J., Capecchi M.R., Underhill T.M., Nielsen T.O. Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Cancer cell 2012, 21:333-347.
24. de Bruijn D.R., Nap J.P., van Kessel A.G. The (epi) genetics of human synovial sarcoma. Genes Chromosomes Cancer 2007, 46:107-117.
25. Xie Y., Skytting B., Nilsson G., Gasbarri A., Haslam K., Bartolazzi A., Brodin B., Mandahl N., Larsson O. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X; 18)(p11.2; q11.2) translocation. Cancer Res. 2002, 62:3861-3867.
26. Tsuda M., Watanabe T., Seki T., Kimura T., Sawa H., Minami A., Akagi T., Isobe K., Nagashima K., Tanaka S. Induction of p21 (WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1. Oncogene 2005, 24:7984-7990.
27. Fernebro J., Francis P., Eden P., Borg A., Panagopoulos I., Mertens F., Vallon-Christersson J., Akerman M., Rydholm A., Bauer H.C., Mandahl N., Nilbert M. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. Int J. Cancer 2006, 118:1165-1172.
28. Saito T., Nagai M., Ladanyi M. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma. Cancer Res. 2006, 66:6919-6927.
29. Terry J., Saito T., Subramanian S., Ruttan C., Antonescu C.R., Goldblum J.R., Downs-Kelly E., Corless C.L., Rubin B.P., van de Rijn M., Ladanyi M., Nielsen T.O. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am. J. Surg. Pathol. 2007, 31:240-246.
30. Barco R., Hunt L.B., Frump A.L., Garcia C.B., Benesh A., Caldwell R.L., Eid J.E. The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway. Mol. Biol. Cell 2007, 18:4003-4012.
31. Haldar M., Hedberg M.L., Hockin M.F., Capecchi M.R. A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice. Cancer Res. 2009, 69:3657-3664.